miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Pathologic features of idiopathic pulmonary fibrosis (IPF) include genetic predisposition, activation of the unfolded protein response, telomere attrition, and cellular senescence. The mechanisms leading to alveolar epithelial cell (AEC) senescence are poorly understood. MicroRNAs (miRNAs) have been reported as regulators of cellular senescence. Senescence markers including p16, p21, p53, and senescence-associated β-galactosidase (SA-βgal) activity were measured in type II AECs from IPF lungs and unused donor lungs. miRNAs were quantified in type II AECs using gene expression arrays and quantitative RT-PCR. Molecular markers of senescence (p16, p21, and p53) were elevated in IPF type II AECs. SA-βgal activity was detected in a greater percentage in type II AECs isolated from IPF patients (23.1%) compared to patients with other interstitial lung diseases (1.2%) or normal controls (0.8%). The relative levels of senescence-associated miRNAs miR-34a, miR-34b, and miR-34c, but not miR-20a, miR-29c, or miR-let-7f were significantly higher in type II AECs from IPF patients. Overexpression of miR-34a, miR-34b, or miR-34c in lung epithelial cells was associated with higher SA-βgal activity (27.8%, 35.1%, and 38.2%, respectively) relative to control treated cells (8.8%). Targets of miR-34 miRNAs, including E2F1, c-Myc, and cyclin E2, were lower in IPF type II AECs. These results show that markers of senescence are uniquely elevated in IPF type II AECs and suggest that the miR-34 family of miRNAs regulate senescence in IPF type II AECs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“cellular senescence has been linked to the pathogenesis of chronic lung diseases such as chronic obstructive pulmonary disease [14, 15] or IPF [16–20].”
From Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo (2017) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to lung fibroblasts, evidence has emerged that alveolar epithelial cells can become senescent in IPF [16, 20, 24].”
From Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo (2017) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“[27] No background subtraction was performed, and the median feature pixel intensity was used as the raw signal before normalization.”
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“[11] Importantly, a subpopulation of type II AECs in IPF lungs stained for SA-βgal (blue cells, Fig 1A and 1B and S1 Fig).”
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Cellular senescence, a condition of stable cell-cycle arrest, is involved in multiple physiologic processes including embryonic development, [42] tumor suppression, [43] tissue repair, [44, 45] and organismal aging.”
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 1×
“Because telomere shortening can lead to senescence [31], these findings suggest senescence may occur in the type II AECs in miR-34 Mediated Senescence in Idiopathic Pulmonary Fibrosis”
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci‐Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38098 · Cited by 3,409
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 1×
“Cellular senescence, a condition of stable cell-cycle arrest, is involved in multiple physiologic processes including embryonic development, [42] tumor suppression, [43] tissue repair, [44, 45] and organismal aging.”
Cited by
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403
Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.170 · Cited by 402
IPF lung fibroblasts have a senescent phenotype
Álvarez, D., Cárdenes, N., Sellarés, J., Bueno, M., Corey, C., Hanumanthu, V. S., Peng, Y., D’Cunha, H., Sembrat, J., Nouraie, M., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00220.2017 · Cited by 342
“TGF- (23) and senescence-associated miRNAs (14).”
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Naikawadi, R. P., Disayabutr, S., Mallavia, B., Donne, M. L., Green, G., La, J. L., Rock, J. R., Looney, M. R., & Wolters, P. J. (2016) · JCI Insight · doi:10.1172/jci.insight.86704 · Cited by 267
Self-citationPan, J., Li, D., Xu, Y., Zhang, J., Wang, Y., Chen, M., Lin, S., Huang, L., Chung, E. J., Citrin, D. E., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.216 · Cited by 242
Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis
Mora, A. L., Bueno, M., & Rojas, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87440 · Cited by 235
The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis
Selman, M., & Pardo, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109482 · Cited by 225
Jiang, C., Liu, G., Luckhardt, T., Antony, V., Zhou, Y., Carter, A. B., Thannickal, V. J., & Liu, R. (2017) · Aging Cell · doi:10.1111/acel.12643 · Cited by 234
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?
Wolters, P. J., Blackwell, T. S., Eickelberg, O., Loyd, J. E., Kaminski, N., Jenkins, G., Maher, T. M., Molina-Molina, M., Noble, P. W., Raghu, G., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30007-9 · Cited by 196
Self-citationFibroblast senescence in the pathology of idiopathic pulmonary fibrosis
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Burgess, J. K., Mutsaers, S. E., Prele, C. M., Schuliga, M., Grainge, C. L., & Knight, D. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2018 · Cited by 163
“From histological tissue sections, epithelial senescence is also a well-documented feature of the disease (30, 41, 57, 66, 96), and, in a murine model, their targeted removal through the use of senolytics leads to an attenuation of profibrotic marker expression and increased epithelial cell function (57).”
BackgroundRana, T., Jiang, C., Liu, G., Miyata, T., Antony, V., Thannickal, V. J., & Liu, R.-M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0071oc · Cited by 157
Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases
Blokland, K. E. C., Pouwels, S. D., Schuliga, M., Knight, D. A., & Burgess, J. K. (2020) · Clinical Science · doi:10.1042/cs20190893 · Cited by 128
Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
Parimon, T., Hohmann, M. S., & Yao, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126214 · Cited by 134
“ER stress and activation of the UPR have been observed in senescence induced by different stimuli and been proposed as the consequence of senescent phenotype [63].”
BackgroundPardo, A., & Selman, M. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0373ps · Cited by 117
Erratum: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.225 · Cited by 128
Senotherapeutics: targeting senescence in idiopathic pulmonary fibrosis
Merkt, W., Bueno, M., Mora, A. L., & Lagares, D. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.008 · Cited by 119
Cell senescence and fibrotic lung diseases
Liu, R.-M., & Liu, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110836 · Cited by 113
Cellular senescence and radiation-induced pulmonary fibrosis
He, Y., Thummuri, D., Zheng, G., Okunieff, P., Citrin, D. E., Vujaskovic, Z., & Zhou, D. (2019) · Translational Research · doi:10.1016/j.trsl.2019.03.006 · Cited by 103
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 110
Shentu, T., Huang, T.-S., Cernelc‐Kohan, M., Chan, J., Wong, S. S., Espinoza, C. R., Tan, C., Gramaglia, I., van der Heyde, H., Chien, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-18288-9 · Cited by 104
The Role of Pathological Aging in Cardiac and Pulmonary Fibrosis
Murtha, L. A., Morten, M., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Ngo, D. T., Sverdlov, A. L., Knight, D. A., et al. (2019) · Aging and disease · doi:10.14336/ad.2018.0601 · Cited by 96
“Markers of senescence are detected in resident cells of human fibrotic heart and lung in situ and after isolation in vitro [18-20].”
BackgroundMitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts
Schuliga, M., Pechkovsky, D. V., Read, J., Waters, D. W., Blokland, K. E. C., Reid, A. T., Hogaboam, C. M., Khalil, N., Burgess, J. K., Prêle, C. M., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13855 · Cited by 97
DePianto, D. J., Heiden, J. A. V., Morshead, K. B., Sun, K.-H., Modrusan, Z., Teng, G., Wolters, P. J., & Arron, J. R. (2021) · JCI Insight · doi:10.1172/jci.insight.143626 · Cited by 92
Self-citationSelman, M., & Pardo, A. (2021) · European Respiratory Journal · doi:10.1183/13993003.04507-2020 · Cited by 100
Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis
Kasper, M., & Barth, K. (2017) · Bioscience Reports · doi:10.1042/bsr20171301 · Cited by 88
Cellular Senescence in Lung Fibrosis
Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137012 · Cited by 76
“Moreover, a PAI1 inhibitor (TM5275) blocked fibrosis in mice with bleomycin-induced lung fibrosis and protected AEC2s from senescence by targeting the p53 pathway [109].”
BackgroundThe controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy
Cao, L., Li, K., Li, Q., Tong, Q., Wang, Y., & Huang, L. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02475-8 · Cited by 90
Yanagi, S., Tsubouchi, H., Miura, A., Matsuo, A., Matsumoto, N., & Nakazato, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030503 · Cited by 80
Senescence in tissue samples of humans with age-related diseases: A systematic review
Tuttle, C. S. L., Luesken, S. W. M., Waaijer, M. E. C., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101334 · Cited by 64
“, 2012), Type II cells (Aoshiba et al., 2012; Disayabutr et al., 2016; Lehmann et al., 2017; Tsuji et al., 2006, 2010), Clara cells (Zhou et al.”
Cellular Senescence in Idiopathic Pulmonary Fibrosis
Kellogg, D. L., Kellogg, D. L., Musi, N., & Nambiar, A. M. (2021) · Current Molecular Biology Reports · doi:10.1007/s40610-021-00145-4 · Cited by 67
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 70
Senescence and tissue fibrosis: opportunities for therapeutic targeting
O’Reilly, S., Tsou, P., & Varga, J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.012 · Cited by 72
MicroRNA-29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis
Xie, T., Liang, J., Geng, Y., Liu, N., Kurkciyan, A., Kulur, V., Leng, D., Deng, N., Liu, Z., Song, J., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0133oc · Cited by 65
Lee, J. Y., Reyes, N. S., Ravishankar, S., Zhou, M., Krasilnikov, M., Ringler, C., Pohan, G., Wilson, C., Ang, K. K. H., Wolters, P. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci173371 · Cited by 63
“…examination of IPF lungs has demonstrated the presence of biomarkers associated with senescence in alveolar type 2 (AT2) cells and lung fibroblasts (18), which was confirmed in single cell atlases of IPF lungs showing enrichment of CDKN2A (encoding p16 INK4a ) expression in epithelial and…”
Self-citationQiu, T., Tian, Y., Gao, Y., Ma, M., Li, H., Liu, X., Wu, H., Zhang, Y., Ding, H. J., Cao, M., et al. (2019) · Aging · doi:10.18632/aging.102262 · Cited by 64
“Senescent epithelial cells secrete several mediators in the SASP, which have been shown to directly influence their surrounding microenvironment, thereby triggering IPF [45].”
BackgroundMALAT1 regulates miR-34a expression in melanoma cells
Li, F., Li, X., Qiao, L., Liu, W., Xu, C., & Wang, X. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1620-3 · Cited by 57
Song, L., Zhou, F., Cheng, L., Hu, M., He, Y., Zhang, B., Liao, D., & Xu, Z. (2017) · Inflammation · doi:10.1007/s10753-017-0537-1 · Cited by 54
“Previous studies have also reported that miR-34a is also involved in various lung diseases and could regulate senescence in alveolar type II epithelial cells of patients with idiopathic pulmonary fibrosis [4].”
ResultKomseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F.-M., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 51
“In addition, miR-34s, including miR34c, were reported to trigger senescence in various human lung settings [104, 105].”
BackgroundFibrosis: Lessons from OMICS analyses of the human lung
Yu, G., Ibarra, G. H., & Kaminski, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.014 · Cited by 52
“Type I epithelial cells are lost and type II epithelial cells are stressed, exhibit senescence markers, shorter telomeres [99] and increased expression of senescence associated microRNAs such as mir-34 [100].”
BackgroundLee, J. S., La, J. L., Aziz, S., Dobrinskikh, E., Brownell, R., Jones, K. D., Achtar‐Zadeh, N., Green, G., Elicker, B. M., Golden, J. A., et al. (2021) · Histopathology · doi:10.1111/his.14334 · Cited by 58
“In IPF, cells reported to express senescence markers include fibroblasts(41,42) and, more prominently, AECII cells.(6,23) Senescent cells may make dual contributions to lung fibrosis, with senescent fibroblasts limiting fibrosis(43,44) and senescent AECII cells promoting lung fibrosis.”
BackgroundMethodInfluentialSelf-citationMolecular Signatures of Idiopathic Pulmonary Fibrosis
Konigsberg, I. R., Borie, R., Walts, A. D., Cardwell, J., Rojas, M., Metzger, F., Hauck, S. M., Fingerlin, T. E., Yang, I. V., & Schwartz, D. A. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0546oc · Cited by 59
“gene for miR-34, which has been shown to regulate cellular senescence in IPF type II alveolar epithelial cells (69).”
BackgroundmiR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
Ge, L., Habiel, D. M., Hansbro, P. M., Kim, R., Gharib, S. A., Edelman, J. D., Königshoff, M., Parimon, T., Brauer, R., Huang, Y., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90301 · Cited by 52
Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis
Guiot, J., Henket, M. A., Remacle, C., Cambier, M., Struman, I., Winandy, M., Moermans, C., Louis, E. J., Malaise, M., Ribbens, C., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02413-6 · Cited by 55
“On the other hand, miR-142-3p [29, 33, 67, 77], miR93-5p [62, 63], miR-96-5p [64, 78], miR-144-3p [64, 73], miR-34b [62, 79], miR-34c [67, 79], miR-192-5p [29, 67], and miR-1275 [73, 75] present a downregulation in COVID-19 and an upregulation in IPF (Table 3).”
Yamada, Z., Nishio, J., Motomura, K., Mizutani, S., Yamada, S., Mikami, T., & Nanki, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.935114 · Cited by 54
miR-34a Regulates Sperm Motility in Zebrafish
Guo, W., Xie, B., Xiong, S., Liang, X., Gui, J., & Mei, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122676 · Cited by 46
“Earlier studies have proved that the miR-34 family acts as regulators of gene expression in cell cycle progression [32], senescence [33], and apoptosis [34].”
BackgroundThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Miao, C., Xiong, Y., Zhang, G., & Chang, J. (2018) · Experimental Lung Research · doi:10.1080/01902148.2018.1455927 · Cited by 45
The Potential Roles of Exosomes in Chronic Obstructive Pulmonary Disease
Wang, N., Wang, Q., Du, T., Gabriel, A. N. A., Wang, X., Sun, L. J., Li, X., Xu, K., Jiang, X., & Zhang, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.618506 · Cited by 44
McErlean, P. K., Bell, C. G., Hewitt, R. J., Busharat, Z., Ogger, P. P., Ghai, P., Albers, G. J., Calamita, E., Kingston, S., Molyneaux, P. L., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202101-0004oc · Cited by 48
Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases
Chen, Y., Yuan, S., Cao, Y., Kong, G., Jiang, F., Li, Y., Wang, Q., Tang, M., Zhang, Q., Wang, Q., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3206982 · Cited by 47
“The activation of p53, after the senescence occurred in type II alveolar epithelial cells, can participate in the development of pulmonary fibrosis by upregulating miR-34 and downregulating key target genes of the cell cycle [37].”
BackgroundKorfei, M., MacKenzie, B., & Meiners, S. (2020) · European Respiratory Review · doi:10.1183/16000617.0126-2020 · Cited by 45
Sakaki, M., Ebihara, Y., Okamura, K., Nakabayashi, K., Igarashi, A., Matsumoto, K., Hata, K., Kobayashi, Y., & Maehara, K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171431 · Cited by 39
Zeng, X., Yang, X.-N., & Liu, X.-J. (2022) · Medicine · doi:10.1097/md.0000000000031944 · Cited by 39
“[41] Disayabutr et al showed that miR-34a expression was increased in alveolar epithelial cells of idiopathic pulmonary fibrosis patients and was positively correlated with SA-β-gal expression.[42] NF-κB, a key transcription factor that regulates proinflammatory genes, has been previously found to control SASP release…”
BackgroundLiang, Z., Kong, R., He, Z., Lin, L., Qin, S., Chen, C., Xie, Z., Yu, F., Sun, G.-Q., Li, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17650 · Cited by 37
Role of Non-Coding RNAs in Post-Transcriptional Regulation of Lung Diseases
Soni, D. K., & Biswas, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.767348 · Cited by 40
microRNA-34 family: From mechanism to potential applications
Wang, C., Jia, Q., Guo, X., Li, K., Chen, W., Shen, Q., Xu, C., & Fu, Y. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106168 · Cited by 39
Selman, M., Martinez, F. J., & Pardo, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1166pp · Cited by 35
Radiation induced apoptosis and pulmonary fibrosis: curcumin an effective intervention?
Johnson, S., Shaikh, S. B., Muneesa, F., Barki, R. R., & Bhandary, Y. P. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1739773 · Cited by 37
“Apoptosis and Plasminogen Activator Inhibitor-1 (PAI-1) play an important role in the pathogenesis and progression of PF. Apoptosis of alveolar epithelial cells in fibrotic foci has been described in a number of settings, including in the lungs of idiopathic PF patients (Disayabutr et al. 2016).”
BackgroundPAI-1 Regulation of p53 Expression and Senescence in Type II Alveolar Epithelial Cells
Rana, T., Jiang, C., Banerjee, S., Yi, N., Zmijewski, J. W., Liu, G., & Liu, R.-M. (2023) · Cells · doi:10.3390/cells12152008 · Cited by 32
Muthuramalingam, K., Cho, M., & Kim, Y. (2019) · Cell Biology International · doi:10.1002/cbin.11248 · Cited by 33
Roth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2023) · Allergy · doi:10.1111/all.15977 · Cited by 35
Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)
Han, S., Lu, Q., & Liu, X. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11844 · Cited by 34
“The mechanism of miR‑34 in IPF may involve p53 activation and downregulation of the transcription factor early 2 factor to inhibit cell proliferation (26).”
C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1
Qin, H., Tang, Y., Mao, Y., Zhou, X., Xu, T., Liu, W., & Su, X. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110274 · Cited by 30
Wang, W., Zhong, G.-Z., Long, K.-B., Liu, Y., Liu, Y., & Xu, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108151 · Cited by 30
Naikawadi, R. P., Green, G., Jones, K. D., Achtar‐Zadeh, N., Mieleszko, J. E., Arnould, I. S., Kukreja, J., Greenland, J. R., & Wolters, P. J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0374oc · Cited by 28
“Telomere dysfunction mediates cellular senescence reprogramming (21, 22), which is implicated as a driver of lung remodeling and fibrosis (15, 23).”
BackgroundSelf-citationMicroRNA-34a: A Novel Therapeutic Target in Fibrosis
Zhao, M., Qi, Q., Liu, S., Huang, R. S., Shen, J., Zhu, Y., Chai, J., Zheng, H., Wu, H., & Liu, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.895242 · Cited by 30
Zheng, Y., Liu, H., & Kong, Y. (2017) · FEBS Letters · doi:10.1002/1873-3468.12720 · Cited by 26
“Although multiple miRNAs have been reported to regulate senescence positively or negatively [18,19], most studies have focused on the effect of miRNAs on the senescence of tumor cells [20,21].”
RetractedTanshinone IIA improves diabetes‐induced renal fibrosis by regulating the miR ‐34‐5p/Notch1 axis
Zhang, L., & Yang, F. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.2998 · Cited by 26
“The results of previous studies have demonstrated a role of miR34a- 5p in fibrosis (Disayabutr et al., 2016; Li et al., 2011); however, the exact role of miR- 34a- 5p in diabetic- induced renal fibrosis is yet to be fully understood.”
ResultUrine-derived exosomes from individuals with IPF carry pro-fibrotic cargo
Elliot, S. J., Catanuto, P., Pereira‐Simon, S., Xia, X., Shahzeidi, S., Roberts, E. R., Ludlow, J. W., Hamdan, S., Daunert, S., Parra, J., et al. (2022) · eLife · doi:10.7554/elife.79543 · Cited by 26
“…changes in miRNA expression as reported in prior studies from patients with IPF (Argyris, Jose, Koji, & Demosthenes, 2016; Cushing et al., 2011; Disayabutr et al., 2016; Elliot et al., 2019; Guiot et al., 2019; Lino Cardenas, Kaminski, & Kass, 2013; Njock et al., 2019; Omote & Sauler, 2020;…”
ResultZhang, Y., Jones, K. D., Achtar‐Zadeh, N., Green, G., Kukreja, J., Xu, B., & Wolters, P. J. (2019) · Histopathology · doi:10.1111/his.13745 · Cited by 26
Self-citationCauses of Pulmonary Fibrosis in the Elderly
Ramírez, C. L., Suárez-Valdivia, L., & Portal, J. A. R. (2018) · Medical Sciences · doi:10.3390/medsci6030058 · Cited by 32
Ulke, H. M., Mutze, K., Lehmann, M., Wagner, D. E., Heinzelmann, K., Günther, A., Eickelberg, O., & Königshoff, M. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0047oc · Cited by 23
Ortíz-Quintero, B., Buendía-Roldán, I., Ramírez-Salazar, E. G., Balderas-Martínez, Y. I., Ramírez-Rodriguez, S. L., Martínez‐Espinosa, K., & Selman, M. (2020) · Cells · doi:10.3390/cells9061556 · Cited by 23
“Interestingly, up-regulation of miR-34 family of miRNAs, which was also increased in our study, also leads to down-regulation of key targets involved in the cell cycle inducing a senescent phenotype in alveolar epithelial cells of IPF lungs [51], possibly driven by p53 activation [52].”
BackgroundTakano, M., Nekomoto, C., Kawami, M., & Yumoto, R. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.002 · Cited by 21
Pang, X., Shi, H., Chen, X., Li, C. R., Shi, B., Yeo, A. J., Lavin, M. F., Jia, Q., Shao, H., Zhang, J., et al. (2022) · Environmental Toxicology · doi:10.1002/tox.23547 · Cited by 19
“This includes idiopathic pulmonary fibrosis and bleomycin mediated pulmonary fibrosis.(27) However, the regulatory role of miRNAs in silicon-mediated pulmonary fibrosis as in silicosis remains”
BackgroundSenescence, oxidative stress and mitochondria dysfunction
Zhu, M.-J., Wang, X., Shi, L., Liang, L., & Wang, Y. (2018) · Medical Research and Innovations · doi:10.15761/mri.1000149 · Cited by 20
“Senescence is a highly potent, cell-independent tumor suppressor that blocks pre-cancerous cell proliferation and further reduces the risk of tumor formation through cell-independent paracrine SASP [30].”
BackgroundFernandez, R. J., Gardner, Z., Slovik, K. J., Liberti, D. C., Estep, K. N., Yang, W., Chen, Q., Santini, G. T., Perez, J. V., Root, S., et al. (2022) · eLife · doi:10.7554/elife.64430 · Cited by 20
MiRNA, a New Treatment Strategy for Pulmonary Fibrosis
Liu, Y., Nie, H., Ding, Y. P., Hou, Y., Mao, K., & Cui, Y. (2020) · Current Drug Targets · doi:10.2174/1874609813666200928141822 · Cited by 21
A New Model of Acute Exacerbation of Experimental Pulmonary Fibrosis in Mice
Yegen, C.-H., Haine, L., Ferreira, K. D. C., Marchant, D., Bernaudin, J., Planès, C., Voituron, N., & Boncoeur, É. (2022) · Cells · doi:10.3390/cells11213379 · Cited by 18
Xuan, W., Wang, S., Alarcón-Calderón, A., Bagwell, M. S., Para, R., Wang, F., Zhang, C., Tian, X., Stalboerger, P. G., Peterson, T. E., et al. (2024) · Translational research · doi:10.1016/j.trsl.2024.02.001 · Cited by 18
IL-4-induced SOX9 confers lineage plasticity to aged adult lung stem cells
Cai, X. T., Jia, M., Heigl, T., Shamir, E. R., Wong, A. K., Hall, B. M., Arlantico, A., Hung, J., Menon, H. G., Darmanis, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114569 · Cited by 20
Licence to kill senescent cells in idiopathic pulmonary fibrosis?
Mailleux, A., & Crestani, B. (2017) · European Respiratory Journal · doi:10.1183/13993003.01360-2017 · Cited by 21
Omote, N., & Sauler, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.603047 · Cited by 17
“through inactivation of SIRT1 and increased mitochondrial dysfunction (118, 119, 124).”
BackgroundSpannbrucker, T., Ale‐Agha, N., Goy, C., Dyballa‐Rukes, N., Jakobs, P., Jander, K., Altschmied, J., Unfried, K., & Haendeler, J. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.11.017 · Cited by 16
“Both diseases show features of premature lung aging and cellular senescence like the accumulation of cell cycle blocking proteins p21 and p16 (Disayabutr et al., 2016; Houssaini et al., 2018) as well as the loss of the redox-sensitive histone deacetylase SIRT1 (Rajendrasozhan et al.”
Fan, G., Liu, J., Wu, Z. S., Li, C., & Zhang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049361 · Cited by 26
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
Özaltin, B., Chapman, R., Arfeen, M. Q. U., Fitzpatick, N., Hemingway, H., Direk, K., & Jacob, J. (2024) · Respiratory Research · doi:10.1186/s12931-024-02875-2 · Cited by 16
Posttranscriptional control of airway inflammation
Ezegbunam, W., & Foronjy, R. (2017) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1455 · Cited by 14
“This miRNA may control lung tissue integrity by its ability to regulate epithelial cell proliferation and cellular senescence.(177,178) However, studies are required to further elucidate the exact role of miR-34c and other miRNA in development of lung tissue destruction in emphysema.”
BackgroundCircular RNAs and their roles in idiopathic pulmonary fibrosis
Surendran, A. M., Huang, C., & Liu, L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02716-2 · Cited by 14
“It also induces ER stress, mitochondrial dysfunction, and imbalances in miRNAs, thereby inducing epithelial injury [28, 35, 36].”
BackgroundWang, C.-J., Li, B., Tan, Y., Zhang, G., Cheng, G., & Ren, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117205 · Cited by 12
Shi, J., Zhou, S., Zhao, J., Xu, D., Huang, H. F., Li, M., Tian, X., He, L., Wu, C., Wang, Q., et al. (2024) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0055 · Cited by 12
“In the lungs of patients with pulmonary fibrosis (PF), miR-34a expression was significantly higher in the type II alveolar epithelial cells (AEC), and this may dysregulate cell senescence [38] and promote epithelial-mesenchymal transition.”
BackgroundFernandez, R. J., & Johnson, F. B. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13692 · Cited by 12
Idiopathic Pulmonary Fibrosis and Lung Cancer: Finding Similarities within Differences
Reyfman, P. A., & Gottardi, C. J. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0172ed · Cited by 12
“But is there another way to view these data, perhaps also accommodating the abundant literature demonstrating epithelial senescence in IPF (7, 8)? Although the upregulated genes shared by NSCLC and IPF are enriched in those that control the “mitosis/cell cycle,” it is important to recognize that such identifiers do no…”
BackgroundZhou, Y., Su, W., Xu, M.-Z., Zhang, A., Li, S., Guo, H., Gong, K., Lu, K., Yu, X., Zhu, Q., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119568 · Cited by 10
Sabater, L., Gossart, J. B., Hernandez, I., Rico, D., Blanchard, A. D., Borthwick, L. A., Fisher, A. J., Majo, J., Jiwa, K., Collins, A., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.12.015 · Cited by 11
Wang, Q., Li, A., Li, Q., Li, Q., Wang, Q., Wu, S., Meng, J., Liu, C., Wang, D., & Chen, Y. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176843 · Cited by 11
Enzel, D., Kriventsov, M. A., Sataieva, T., & Malygina, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168946 · Cited by 12
“Among others, there is evidence indicating the role of various epigenetic mechanisms, in particular, miRNA-34a [104,105].”
BackgroundThe Role of p53‐Mediated Cellular Senescence in Idiopathic Pulmonary Fibrosis
Jin, Y., Jiang, M., Bu, W., Zhou, Y., Tang, J., Bao, S., Zhao, R., Zhao, X., & Cheng, D. (2025) · Comprehensive physiology · doi:10.1002/cph4.70041 · Cited by 9
IPF and CPFE—The Two Different Entities or Two Different Presentations of the Same Disease?
Kwiatkowska, S. (2017) · Advances in respiratory medicine · doi:10.5603/arm.a2017.0049 · Cited by 8
“Furthermore, it was revealed that the process is mainly regulated by microRNA-34a [22].”
BackgroundThe impact of cellular senescence on aging skeletal muscle
Kamal, M. J., Bevington, R. T., Johnson, A., & Parise, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1719279 · Cited by 8
Construction of a TFs-miRNA-mRNA network related to idiopathic pulmonary fibrosis
Su, M., Liu, J., Wu, X. S., Chen, X., Xiao, Q., & Jiang, N. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-6161 · Cited by 7
“In previous studies (38-40), miR - 34a was found to be elevated in IPF tissues and inhibit cellular senescence through SIRT1 in Alveolar epithelial cells (AECs) and fibroblasts.”
Metadata
- Authors
- Disayabutr, S., Kim, E. K., Cha, S.-I., Green, G., Naikawadi, R. P., Jones, K. D., Golden, J. A., Schroeder, A., Matthay, M. A., Kukreja, J., Erle, D. J., Collard, H. R., & Wolters, P. J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Wolters, Paul J.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-06-30
- Volume
- 11
- Issue
- 6
- Pages
- e0158367
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4928999
- OpenAlex
- W2463253169
- Cited by
- 136
- References
- 54
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 13 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 18 · 2019: 12 · 2018: 17 · 2017: 22 · 2016: 2
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Nina Ireland Program in Lung Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Keywords
- idiopathic pulmonary fibrosis, cellular senescence, alveolar type II cells, miR-34 family, microRNA, senescence-associated β-galactosidase, p16, p21, p53, E2F1, c-Myc, cyclin E2, unfolded protein response, telomere shortening
- MeSH terms
- A549 Cells, Gene Expression Regulation, Humans, Lung, Biomarkers, Case-Control Studies, Cellular Senescence, Disease Progression, Gene Expression Profiling, MicroRNAs, Microarray Analysis, Idiopathic Pulmonary Fibrosis, Alveolar Epithelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.